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Abstract 57 
Network hyperexcitability is a feature of Alzheimer’s disease (AD) as well as 58 
numerous transgenic mouse models of AD. While hyperexcitability in AD 59 
patients and AD animal models share certain features, the mechanistic overlap 60 
remains to be established. We aimed to identify features of network 61 
hyperexcitability in AD models that can be related to epileptiform activity 62 
signatures in AD patients. We studied network hyperexcitability in mice 63 
expressing amyloid precursor protein (APP) with mutations that cause familial 64 
AD, and compared a transgenic model that overexpresses human APP (J20), to a 65 
knock-in model expressing APP at physiological levels (APPNL/F). We recorded 66 
continuous long-term electrocorticogram activity from mice, and studied 67 
modulation by circadian cycle, behavioural, and brain state. We report that while 68 
J20s exhibit frequent inter-ictal spikes (IIS), APPNL/F mice do not. In J20 mice, IIS 69 
were most prevalent during daylight hours and the circadian modulation was 70 
associated with sleep. Further analysis of brain state revealed that IIS in J20s are 71 
associated with features of rapid-eye movement (REM) sleep. We found no 72 
evidence of cholinergic changes that may contribute to IIS-circadian coupling in 73 
J20s. In contrast to J20s, intracranial recordings capturing IIS in AD patients 74 
demonstrated frequent IIS in non-REM sleep. The salient differences in sleep-75 
stage coupling of IIS in APP overexpressing mice and AD patients suggests that 76 
different mechanisms may underlie network hyperexcitability in mice and 77 
humans.  We posit that sleep-stage coupling of IIS should be an important 78 
consideration in identifying mouse AD models that most closely recapitulate 79 
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network hyperexcitability in human AD.  80 
 81 
Significance statement 82 
It is increasingly recognized that Alzheimer’s disease (AD) is associated with 83 
hyperexcitability in brain networks. Brain network hyperexcitability is also 84 
reported in several rodent models of AD. We studied the signatures of this 85 
hyperexcitability in two rodent models of AD as well as AD patients. Network 86 
hyperexcitability was prevalent in a transgenic model of AD, but was absent in a 87 
rodent model that is considered to be more physiological. Moreover, while 88 
network hyperexcitability was coupled to rapid-eye movement (REM) sleep in 89 
transgenic mice, hyperexcitability occurred in non-REM sleep in AD patients. We 90 
suggest that brain state coupling of hyperexcitability can be used as a method for 91 
screening animal models of AD. 92 
  93 
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Introduction 94 
An increased incidence of seizures in Alzheimer’s disease (AD) is indicative of an 95 
underlying network hyperexcitability (Hesdorffer et al., 1996; Amatniek et al., 96 
2006; Lozsadi and Larner, 2006; Vossel et al., 2013; Cretin et al., 2016). Inter-97 
ictal spikes (IIS) are also seen in a high proportion of AD patients without a 98 
history of clinical seizures (Vossel et al., 2016).   Non-ictal network hyperactivity 99 
has also been detected by means of fMRI in individuals at risk of developing 100 
dementia, for example in people carrying the APOE4 allele (Bookheimer et al., 101 
2000; Filippini et al., 2009), with other genetic predictors of AD (Quiroz et al., 102 
2010) and also in patients with mild cognitive impairment – a diagnosis which is 103 
considered to be a prodromal stage of AD (Dickerson et al., 2005). Network 104 
hyperexcitability and seizure activity appear at early stages of the disease and 105 
have been suggested to be predictors of accelerated cognitive decline (Amatniek 106 
et al., 2006; Vossel et al., 2013; Cretin et al., 2016; Vossel et al., 2016). 107 
 108 
Network hyperexcitability has also been reported in numerous mouse models of 109 
AD pathology (Palop et al., 2007; Minkeviciene et al., 2009; Busche et al., 2012; 110 
Šišková et al., 2014; Kazim et al., 2017), with the aberrant activity being a feature 111 
that occurs in advance of plaque deposition (Busche et al., 2012; Bezzina et al., 112 
2015). These phenomenological similarities have led to the suggestion that these 113 
animal models can provide a tool by which to study network hyperexcitability in 114 
human AD (Palop and Mucke, 2016). 115 
 116 
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Aberrant network activity could in itself contribute to neurodegeneration and 117 
cognitive dysfunction in AD pathology (Cirrito et al., 2005; Bero et al., 2011; 118 
Busche and Konnerth, 2015; Wu et al., 2016). Reducing network 119 
hyperexcitability has been shown to ameliorate cognitive dysfunction in both 120 
patients and animal models (Bakker et al., 2012; Sanchez et al., 2012; Haberman 121 
et al., 2017), and to attenuate AE pathology (Yuan and Grutzendler, 2016). Hence, 122 
targeting network hyperexcitability has been suggested as a novel therapeutic 123 
avenue for AD. However, studying this therapeutic avenue by means of animal 124 
models (Sanchez et al., 2012) requires a deeper understanding of the shared 125 
features of network hyperexcitability between AD patients and animal models. 126 
 127 
Expression of epileptiform activity frequently exhibits a circadian pattern and 128 
shows preferential activation with specific brain states in a range of epilepsies 129 
(Quigg, 2000; Ng and Pavlova, 2013; Sedigh-Sarvestani et al., 2015). Circadian 130 
dysfunction and sleep disruption are common features of AD, and are also 131 
considered as early features of disease pathogenesis (Musiek et al., 2015; 132 
Mander et al., 2016; Musiek et al., 2018). Two recent papers have reported 133 
modulation of epileptiform activity by circadian cycle and brain state in 134 
transgenic AD models. Epileptiform activity was more prevalent in daylight 135 
conditions, and was suggested to occur primarily during REM sleep (Born et al., 136 
2014; Kam et al., 2016). If epileptiform activity is modulated by circadian-cycles 137 
and/or brain state in AD patients, it is possible that this might contribute to the 138 
reported circadian alterations and sleep dysfunction. In line with this, it has 139 
recently been shown that inter-ictal activity in AD patients is highly prevalent 140 
during sleep (Vossel et al., 2016; Horváth et al., 2017; Lam et al., 2017). The 141 
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modulation of ictal related activity by brain state points to a distinguishing 142 
feature that could be used to (a) uncover distinct mechanisms underlying 143 
hyperexcitability, and (b) ascertain the translational utility of specific animal 144 
models in studying network hyperexcitability.  To this end, the present study 145 
aimed to investigate circadian and brain state modulation of network 146 
hyperexcitability in two rodent models of AD of differing aetiology: one in which 147 
hAPP is overexpressed and one in which APP is expressed at endogenous levels.  148 
In order to shed light on the translational utility of rodent AD models for 149 
studying network hyperexcitability in human AD, we further examined sleep-150 
stage modulation of epileptiform activity in two patients with AD, using 151 
recordings from intracranial electrodes placed directly adjacent to the 152 
hippocampus.  153 
 154 
Methods 155 
Animals and animal maintenance 156 
All animal procedures were performed in accordance with the [Author 157 
University] animal welfare committee regulations and were performed under a 158 
UK Home Office project license. 159 
 160 
Heterozygous mice expressing hAPP with the KM670/671NL (Swedish) and 161 
V717F (Indiana) mutations on a PDGFEpromoter (J20; Mucke et al., 2000) were 162 
bred by crossing J20 +/- males with C57Bl6J females. Experiments used J20+/- 163 
(n=21) and J20 -/- (n=8) wild-type (WT) littermate controls. The mean age of J20 164 
animals was 5 months (range: 3.3 – 6.5 months). 165 
 166 
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Homozygous knock-in mice expressing APP KM670/671NL (Swedish) and APP 167 
I716F (Iberian) mutations (APPNL/F ; Saito et al., 2014) were back-crossed onto 168 
C57Bl6J strain for at least 3 generations and were >99.8% cogenic with C57Bl6J. 169 
Experiments used APPNL/F +/+ (n=20) and age-matched non-littermate C57Bl6J 170 
WT controls (n=15). Animals were either 8 months or 12 months of age. 171 
 172 
Both male and female mice were used. Mice were kept on a 7h-19h light-dark 173 
cycle in standard, open cages. Mice were group-housed prior to surgery and 174 
were housed individually post-surgery and during telemetry data acquisition. 175 
 176 
Surgery and data acquisition 177 
A subdural intracranial electrocorticogram (ECoG) recording electrode was 178 
positioned in the cortex overlying the hippocampus (co-ordinates x: -2.25 y: -179 
2.46). A reference electrode was implanted either in the skull of the contralateral 180 
hemisphere, or above the cerebellum. Electrodes were either bare wire, or skull 181 
screws. An EEG transmitter (A3028B, Open Source Instruments) was implanted 182 
on the back of the animal subcutaneously. Animals were left to recover for at 183 
least 24 hours after surgery before the commencement of telemetry data 184 
acquisition. Telemetric ECoG data was acquired for approximately 3 days from 185 
each animal. Recording was either carried out continuously between days 1 to 186 
day 3 after surgery, or day 1, followed by day 5 to day 6.  187 
 188 
ECoG data was acquired using an Opensource Instruments data acquisition 189 
system at 512sps as previously described (Chang et al., 2011). 190 
 191 
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Video data was acquired using a Basler aca1300-60gm gigE camera sampling at 192 
10fps, or a Logitech C270 HD webcam sampling at 5fps. Video was acquired 193 
during the daylight hours.  194 
 195 
ECoG Data processing 196 
The raw ECoG data was analysed using custom written Tcl and C processors. 197 
ECoG data was analysed in 8s intervals. For each interval we extracted measures 198 
of data loss, spike count, delta power (0.1-3.9 Hz) and theta power (4-12 Hz). We 199 
defined intervals in which data loss exceeded 20% of samples as “lossy” intervals. 200 
Intervals in which delta power exceeded 0.16mV2 were classified as artifacts. 201 
Lossy and artifact intervals were excluded.  202 
 203 
Inter-ictal spikes (IIS) in rodent ECoG were detected as follows. Each 8-s interval 204 
of EEG was treated as a two-dimensional path. One dimension is voltage, which 205 
was normalized by dividing by the mean absolute step size of the voltage in the 206 
8-s interval. The mean absolute step size is the sum of the absolute changes in 207 
voltage from one sample to the next, divided by the number of samples. For an 8-208 
s interval, the number of samples would be 4096 and a typical mean absolute 209 
step size for mouse EEG is around 12 μV. The other dimension is time, which was 210 
normalized by dividing by the sample period. The spike-finder proceeds along 211 
this EEG path in steps. With each step, it moves to the nearest sample on the path 212 
ahead. Whenever the spike-finder steps past one or more samples, it classifies 213 
these samples as an aberration in the path.  Solitary aberrations larger than 20 214 
mean absolute step sizes are classified as IIS. A series of IIS in which single 215 
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spikes were separated by <78ms  (40 samples) were treated as a burst event and 216 
counted as one IIS event within the 8s interval. 217 
 218 
For each J20 animal, the false positive rate of IIS detection was determined by 219 
randomly hopping through 100 8s intervals identified by the processor as 220 
containing IIS, and scoring them as true or false positives. The animal was 221 
excluded from analysis if the false positive rate exceeded 10%. One animal was 222 
excluded from analysis on this basis. In the remaining animals, the false positive 223 
rate ranged from 0 – 6% (mean false positive rate: 1.9%). 224 
 225 
We observed that lossy and artifactual intervals resulted from movement and 226 
external sources of interference. We could not exclude the possibility that these 227 
events are non-randomly distributed across the 24hr cycle.  Non-random 228 
exclusion of intervals would impact the evaluation of coupling of IIS. We thus set 229 
a criterion: if >5% of all 8s intervals were excluded due loss or artifact, the 230 
animal was excluded from calculations of coupling of IIS to circadian cycles, 231 
sleep-wake, and TG. Two J20 animals were excluded from data reported in Fig 2-232 
4 on this basis (25% and 16% of 8s intervals excluded in these animals). 233 
 234 
Video analysis 235 
Video data was manually scored to classify periods as ‘sleep’ or ‘wake’.  Based on 236 
previous reports, sustained inactivity ≥40s was classified as ‘sleep’, while 237 
stationary periods <40s and periods of movement were classified as ‘wake’ (Pack 238 
et al., 2007). Postural shifts during sleep epochs did not break sleep epochs.  239 
 240 
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Immunohistochemistry and imaging  241 
Animals were killed by transcardial perfusion with N-methyl-D-glucamine 242 
(NMDG)-based saline solution (in mM: 92 NMDG, 2.5 KCl, 1.25 NaH2PO4, 20 243 
HEPES, 30 NaHCO3, 25 glucose, 10 MgCl2, 0.5 CaCl2, sucrose to adjust osmolarity 244 
to 315-330mOsm). Brains were post-fixed with 4% paraformaldehyde for 24h 245 
then washed and stored in PBS. Samples were put in 50% or 30% sucrose, PBS 246 
solution and 50% OCT solution for 24h before cutting, then placed in the same 247 
solution and cut using a freezing microtome. 248 
 249 
50μm sections were stored in PBS at 4°C. Slices were presoaked with 5% rabbit 250 
normal serum (RNS, Vector S-5000), 0.2% Triton X-100, PBS solution for 30min 251 
at room temperature (RT), followed by incubation with 3% RNS, 0.2% Triton X-252 
100, anti-Choline Acetyltransferase (ChAT; 1:500, Millipore #AB144P, RRID:  253 
AB_2079751), PBS solution for 48h at 4°C. The sections were washed 3 times 254 
with PBS 0.2% Triton X-100 for 5min each and then incubated in 3% RNS, anti-255 
Goat biotinylated (1:200), Dapi (1:5000, Sigma D9542-1MG), PBS solution for 1h 256 
at RT. After 3 PBS 0.2% Triton X-100 washings of 5min each, the sections were 257 
incubated with ABC reagent (Vectastain PK-6105 kit) prepared half an hour 258 
before using and stored in foil at 4°C containing 0.1% of A, 0.1% of B, 0.01% 259 
Triton X-100, PBS for 1h at RT. After 6 PBS washings of 10min each, the sections 260 
were put in 3 3'-diaminobenzidine (Sigma D5905-50TAB), 0.02% CoCl2 (1% 261 
wt/vol), 0,04% (NH4)2Ni(SO4)2 (1% wt/vol) dH20 solution for 30min at 4°C over 262 
agitation. Then stained by adding 1.2% of fresh 1% H202 per slice for 10 to 20s 263 
until the slice darkened. The slices were then transferred and washed in PBS, 6 264 
times for 10min each, mounted on a slide and dried for 30min at 50°C then 265 
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finally covered with Mowiol Embedding Medium and coverslips. Slides were 266 
stored at RT.  267 
 268 
Imaging was performed on a Zeiss AX10 microscope using StereoInvestigator 269 
Software with a 5x/0.16 (420630-9900) apochromat air objective.  270 
Quantification was performed using StereoInvestigator Software “Optical 271 
Fractioner Workflow” probe with the following settings. Thickness of 50μm was 272 
manually defined and regions were selected using a 1.25x/0.03 (420310-9900) 273 
apochromat air objective for low magnification and then counted with a 274 
10x/0.45 (420640-9900) apochromat air objective for high magnification. The 275 
border between medial septum (MS) and diagonal band of Broca (DB) was 276 
defined as a line between the two major island of Caleja. The regions were 277 
separated using different lines. The counting frame used was a square of 75μm 278 
size and the grid was a square of 150μm size. The counter was blind to genotype. 279 
 280 
Oral administration of Donepezil 281 
Donepezil hydrochloride (Sigma Aldrich, D6821) was orally administered in a 282 
jelly. Mice were trained to voluntarily consume jelly following the protocol 283 
described by Zhang (2011). Mice were given placebo jelly or a jelly containing a 284 
Donepezil dose of 1.8mg/kg. For experiments studying the effects of Donepezil 285 
on acetylcholinesterase (AChE) activity, jelly was given at 8am daily. For 286 
experiments studying the effects of Donepezil on IIS, jelly was given daily at 287 
either 8am, or 8pm to assess interactions of AChE modulation and circadian 288 
cycle. Since there was no effect of AChE on IIS, results were pooled. 289 
 290 
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Acetylcholinestrase (AChE) assay 291 
Quantitative measurements of AChE enzymic activity were made using a 292 
modified Ellman method (Ellman et al., 1961; Rosenfeld et al., 2001). Stock 293 
solutions were acetylthiocholine iodide, used as the enzymic substrate (ATH; 1.7 294 
mg/ml in PBS, Sigma-Aldrich), 5,5’-dithio-bis(2-nitrobenzoic acid) (DTNB, 0.8 295 
mg/ml in PBS, Sigma-Aldrich). Briefly, brains were rapidly dissected from either 296 
WT or J20 mice. Neocortex was isolated, weighed and then homogenised using a 297 
Pellet Pestle (Sigma, Z 359971) in 9 volumes of 0.1M sodium phosphate buffer 298 
(pH 7.4) (Patel et al., 2014). 5 μl of brain homogenate was aliquoted into each 299 
well of a 96 –well plate, volume made up to 200 μl with PBS. DTNB (50 μl from 300 
stock) was added, followed by 50 μl of ATH substrate from stock. Measurement 301 
of absorption at 450 nm began immediately (<2 hours from dissection) and was 302 
measured every 5 mins for up to 30 mins using a MRX microplate reader (Dynex 303 
Technologies, Chantilly, USA). Thiocholine production in the test wells was 304 
expressed in units of nmoles/minute, calibrated with reference to the 305 
absorbance change over a range of concentrations giving a linear response using 306 
glutathione as the DTNB reactant (Eyer et al., 2003).  Neostigmine (10 μM, 307 
Sigma-Aldrich) was used to completely inhibit AChE activity and establish there 308 
was no baseline drift during the measurements. 309 
 310 
Human scalp EEG and foramen ovale (FO) electrode recordings  311 
Human scalp EEG and FO electrode recordings were performed at the 312 
Massachusetts General Hospital, as described in detail previously (Lam et al., 313 
2017). Scalp EEG electrodes were placed using the International 10-20 system, 314 
with additional T1 and T2 electrodes.   315 
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 316 
Sleep staging in patient data was performed by a board-certified clinical 317 
neurophysiologist (ADL) based on visual analysis of the full scalp EEG data.  318 
While dedicated electrooculogram and electromyogram channels were not 319 
recorded for these studies, the frontopolar scalp EEG electrodes allowed 320 
assessment of eye movements, while the frontopolar, frontal, and temporal 321 
electrodes allowed assessment of myogenic activity.  Scalp EEG data was 322 
reviewed in 30 second epochs in the longitudinal anterior-posterior bipolar 323 
montage, using the Python module wonambi (https://github.com/wonambi-324 
python/wonambi).  Each 30 second epoch was classified as awake, NREM1, 325 
NREM2, NREM3, or REM, based on the American Academy for Sleep Medicine’s 326 
manual for sleep scoring.    327 
 328 
Spike quantification in patient data was performed by a board-certified clinical 329 
neurophysiologist (ADL), using a custom-made GUI in Matlab (Mathworks, 330 
Natick, MA).  The GUI displayed 15 second epochs of left and right sided FO data, 331 
in both bipolar and common reference montages (common reference = C2), 332 
along with the EKG trace to allow exclusion of EKG artifact. The reviewer could 333 
adjust amplitudes for each trace as needed.  For the MCI patient analyzed, 334 
contact #3 from the left FO electrode did not record properly and was excluded 335 
from analysis.  The reviewer marked all spikes in each epoch.  Epochs were 336 
presented in consecutive order, but the reviewer was otherwise blinded to the 337 
sleep stage for each epoch during the review.  Instantaneous spike rates were 338 
calculated by determining the total number of left FO and right FO spikes 339 
detected within all 30 second epochs of the recording (which corresponded to 340 
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the sleep staging epochs above), and converting these rates to spikes per hour. 341 
Average spike rates within each sleep stage were calculated by summing the 342 
total number of spikes that occurred during each sleep stage and dividing by the 343 
total number of hours the patient spent in each respective sleep stage in the 344 
recording.   345 
 346 
Spectral analysis of the FO electrodes was performed in Matlab, using the freely 347 
available Chronux toolbox (Mitra and Bokil, 2007). Analysis was performed on 348 
the LFO1, LFO2, RFO1, and RFO2 channels, as these were the deepest contacts 349 
and thus least prone to noise or artifact.  Channels were each normalized to zero-350 
mean, unit-variance.  Multi-taper spectrograms were calculated for each 351 
normalized channel, using the Chronux script mtspecgramc with the following 352 
parameters:  frequency range: 1-20Hz, window: 30 seconds; step size: 30 353 
seconds; time-bandwidth product: 3, tapers: 5. This provided a spectral 354 
resolution of 0.2Hz.  An average spectrogram across all FO channels was then 355 
generated, and the average spectral powers within the G band (0-4Hz) and T 356 
band (4-12Hz) were then calculated.    357 
 358 
Statistics  359 
Statistical data analysis was performed using R (version 3.2.0) including the 360 
‘dplyr’ (Wickham et al., n.d.) and ggplot2 (Wickham, 2009) packages.  361 
 362 
Assumptions for parametric tests were tested using Q-Q plots and residual plots. 363 
Data transformations or non-parametric tests were used for two-group 364 
comparisons in which test assumptions were violated. 365 
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 366 
For evaluating the effects of the fixed effects of age and genotype on the 367 
proportion of intervals containing more than one spike in APPNL/F animals, the 368 
data first underwent a square-root transformation and then fit using a linear 369 
model: 370 
ඥܫ݊ݐ݁ݎݒ݈ܽܲݎ݋݌݋ݎݐ݅݋̱݊ܣ݃݁ ൅ ܩ݁݊݋ݐݕ݌݁ ൅ ߦ 
 371 
where [is the error term.  372 
 373 
The time of IIS was treated as circular variable. Each interval in which 1 or more 374 
IIS were detected was considered an event. The time of each event was evaluated 375 
as a phase of a circadian cycle. Circular data was analysed using circular statistics 376 
by means of the ‘circular’ package (Agostinelli and Lund, 2013). Circular outliers 377 
were identified using ‘CircOutlier’ package (Rambli et al., 2016).  378 
 379 
For tests entailing random variables, linear models were fit using ‘lme4’(Bates et 380 
al., 2015). Significance was tested using a log-likelihood test comparing the full 381 
model to a null model without the factor of interest. 382 
 383 
For evaluation of the relationship between spike count and TG, we described 384 
each TGvalue as a member of one of three levels: i) TG≤ 1; ii) 1 < TG≤ 2, and iii) 385 
TG>2.  We then modelled spike count (Poisson-distributed) as a function of 386 
levels of TG, using the R package ‘MCMCglmm’ (Hadfield, 2010). It should be 387 
noted that due to poor properties of a single model fitted across all animals 388 
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(fitting animal as a random effect and TGfactor as a fixed effect), separate 389 
models were fitted to individual animals without including a random effect. Thus 390 
the data do not allow for inference about the population. 391 
 392 
Event-triggered averages of IIS were evaluated by considering each interval in 393 
which an IIS was detected as an event. If no intervals within +- 80s around the 394 
event were excluded, then the 160s window was included in the calculation of 395 
the event-triggered averages, else the event was excluded from the averaging. An 396 
event-triggered average was also evaluated around 2000 randomly sampled 397 
points. 398 
 399 
For comparing TGin intervals with IIS to TGin intervals preceding IIS, we 400 
considered only interval pairs where the preceding interval did not contain IIS 401 
and fit the model 402 
ቀߠ ߜൗ ቁ
ଵ
ସൗ ̱ܫ݊݀݁ݔ ൅ ܵݑܾ݆݁ܿݐ ൅ ߦ 
where Index was a factor labelling whether the interval contained IIS or the 403 
preceding interval and modelled as a fixed effect, and Subject was a random 404 
effect with a random intercept. 405 
  406 
For comparison of ChAT+ cells between genotypes, the model used was: 407 
ܧݏݐ݅݉ܽݐ݁݀ܥ݋ݑ݊ݐ̱ܩ݁݊݋ݐݕ݌݁ ൅ ܴ݁݃݅݋݊ ൅ ܵݑܾ݆݁ܿݐ ൅ ߦ 
 408 
where genotype and region were fixed effects and subject was a random effect 409 
with a random intercept. 410 
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 411 
To study the effect of genotype and treatment of the Thiocholine production rate, 412 
the data of Thiocholine production was log-transformed. The model used was 413 
ሺ݄ܶ݅݋݄ܿ݋݈ܴ݅݊݁ܽݐ݁ሻ̱ܩ݁݊݋ݐݕ݌݁ܶݎ݁ܽݐ݉݁݊ݐ ൅ ܴ݁݌݁ܽݐܫܦ ൅ ߦ 
 414 
where GenotypeTreatment was a fixed effect and RepeatID was a random effect 415 
with a random intercept. Post-hoc tests for the linear model were performed 416 
using package ‘multcomp’ with the Holm correction method (Hothorn et al., 417 
2008). It should be noted that while the treatment levels of control and 418 
donepezil were independent, the neostigmine treatment was applied to a sample 419 
of wild-type control tissue and thus was not independent. This repeated factor 420 
was not accounted for in the model. 421 
 422 
Significance was tested using D=0.05. Two-sided hypothesis testing was used. 423 
 424 
Superscripts following statistical reporting in the results section refer to the 425 
statistical table (Table 1). 426 
 427 
Code and data accessibility 428 
The processor script used for quantification of IIS, T and G power in rodent ECoG 429 
data is available from 430 
http://www.opensourceinstruments.com/Electronics/A3018/HTML/SCPP4V1.t431 
cl 432 
Code used for quantifying IIS in human data is available from  433 
https://github.com/mauriceaj/GUI-EEG_Spike_Annotation 434 
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Network hyperexcitability in mouse models of AD pathology  439 
To establish circadian patterns of network hyperexcitability in J20 mice, we 440 
recorded ECoG activity from freely-moving J20 and littermate wild-type (WT) 441 
mice using wireless telemetry over a period of three days. As network 442 
excitability has been suggested to be an early event in AD pathogenesis (Vossel 443 
et al., 2013; Sarkis et al., 2015), we focused our study on ages which precede 444 
overt plaque pathology in J20s (Mucke et al., 2000).  445 
 446 
As previously reported (Palop et al., 2007), non-seizure, inter-ictal spikes (IIS; 447 
Fig 1A) were detected in J20 ECoG (note that while ictal activity was not assessed, 448 
we refer to these as inter-ictal events due to the similarity with IIS that have 449 
been reported in the literature) . We applied automated event detection (see 450 
methods), on 8s intervals of continuous ECoG.  The percentage of intervals in 451 
which 1 or more spikes were detected was negligible in WTs (mean percentage: 452 
0.8%, sd=0.7%, n=8). In contrast, the percentage of intervals with 1 or more 453 
spikes was greater in J20s (mean percentage: 11.6%, sd=5.1%, n=18; t=10.6, 454 
df=23.98, p<0.0001, t-test on square root transformed data with Welch 455 
correction, Figure 1B,C)a.  456 
 457 
Seizures and IIS have been reported in numerous strains of transgenic mice that 458 
express hAPP and that exhibit AE pathology (Del Vecchio et al., 2004; Palop et al., 459 
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2007; Minkeviciene et al., 2009; Rasch and Born, 2013). However, it has been 460 
suggested that such network hyperexcitability is the result of overexpression of 461 
hAPP (Born et al., 2014). To determine whether network hyperexcitability is 462 
associated with AE pathology in the absence of hAPP overexpression, we 463 
performed telemetric ECoG recordings as above, in mice expressing the 464 
humanized AE sequence of APP (APPNL/F; Saito et al., 2014) and age-matched 465 
controls. We recorded from mice at ages preceding overt plaque pathology (8 466 
months) and at ages where plaques begin to appear (12 months)(Saito et al., 467 
2014; Masuda et al., 2016). We found no significant effect of genotype in the 468 
proportion of intervals containing spikes between WT and APPNL/F (Fig 1D; F(2, 469 
32)=3.1, R2=0.11, p=0.06)b with a negligible proportion of intervals with one or 470 
more spikes detected (mean percentage of intervals with one or more spikes, 471 
pooled across genotype and age = 1.2%, 95%CI (0.8%, 1.6%)).  A post-hoc power 472 
calculation based on the effect size from the J20 group (Cohen’s d=2.5) and the 473 
sample sizes of the APPNL/F and WT groups yielded a power of >0.99 at D=0.05 474 
for an effect of genotype. Hence, we conclude that APPNL/F mice show no 475 
evidence of network hyperexcitability compared to control animals. 476 
 477 
Circadian coupling of IIS 478 
It has been suggested that seizure-related activity shows circadian fluctuations 479 
in epilepsies (Quigg, 2000). Hence we next asked whether the likelihood of IIS in 480 
J20s varies across the day/night cycle. Quantifying the number of IIS per hour 481 
revealed that IIS are more frequent during daylight hours (inactive phase; Fig 482 
2A). We used circular statistics to extract measures of the phase coupling of IIS 483 
to the circadian cycle within individual J20 animals (Fig 2A, see methods). To 484 
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evaluate the degree of phase coupling of IIS in each animal, we evaluated the 485 
mean angular vector length (U) from the time of IIS. U can vary between 0 (no 486 
phase coupling) to 1 (perfect phase coupling). To evaluate the time to which IIS 487 
were coupled, we extracted the mean coupling phase off IIS, expressed as a time 488 
on a 24-hour cycle (߮ூூௌ). 489 
 490 
The distribution of IIS phases differed significantly from a random distribution in 491 
all animals (Rayleigh Test of Uniformity:  p<10-11). The extent of phase coupling 492 
was variable across the sample of J20s (Fig 2B; mean UIIS=0.24, sd=0.13, n=16).  493 
 494 
Evaluating the coupling phase revealed that IIS occurred predominantly in the 495 
light condition (Fig 2A). Across the sample of J20s, the mean߮ூூௌ  (߮ூூௌതതതതത) 496 
confirmed this (Fig 2B; ߮ூூௌതതതതത = 15h05, U =0.38, n=16, p < 0.0001, Rayleigh’s test). 497 
Inspection of the ߮ூூௌ distribution revealed potential outliers. Testing for outliers 498 
on a circular distribution (Rambli et al., 2016) identified four outliers. These four 499 
animals were amongst the 5 that showed a cluster of weakest phase coupling as 500 
measured by UIIS (range: 0.06 – 0.11).  We used the upper bound of the range of 501 
UIIS of the four outlier animals to classify phase-coupling as weak or strong. 502 
Henceforth, we refer to the five animals with UIIS  ≤ 0.11 as showing weak phase-503 
coupling, and the other 11 animals as showing strong phase-coupling (UIIS>0.17).  504 
 505 
Sleep/wake modulation of IIS 506 
Since IIS predominantly occurred in the normal inactive phase of the circadian 507 
cycle, we next asked whether this circadian modulation of IIS could be accounted 508 
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for by the sleep/wake state of the animals. In a subset of J20s, we acquired 509 
simultaneous video recordings while recording ECoG data (n=4). We manually 510 
scored the video and classified periods as ‘sleep’ or ‘wake’ (see Methods). Two of 511 
these four J20 animals showed strong circadian phase-coupling of IIS, and two 512 
showed weak phase-coupling. For the two animals that showed strong phase-513 
coupling of IIS, IIS occurred more frequently in sleep than during waking (Fig 3A, 514 
B). In contrast, the modulation of IIS probability did not show a consistent 515 
pattern in animals showing weak phase-coupling (Fig 3B). This suggests that the 516 
strong phase-coupling of IIS may be accounted for by differences in behavioural 517 
state across the circadian cycle. 518 
 519 
Brain state modulation of IIS in J20 mice 520 
Sleep-related ictal and inter-ictal activity is differentially modulated by REM and 521 
NREM sleep in different forms of epilepsy (Bazil and Walczak, 1997; Herman et 522 
al., 2001; Sedigh-Sarvestani et al., 2014; Ewell et al., 2015). REM and NREM can 523 
be distinguished by the relative power in the G (defined here as 0.1 – 3.9 Hz) and 524 
T (4- 12 Hz) frequency bands, with high TG associated with REM (Ewell et al., 525 
2015) as well as waking exploration (Buzsáki, 2002). Thus, we next asked 526 
whether IIS are more likely to occur in particular brain states. To this end, we 527 
performed spectral analysis of the ECoG data from a subset of the mice (n=5 528 
J20s) in which a reference electrode was implanted at cerebellar coordinates (a 529 
non-cortical reference for detection of cortical rhythms). ECoG recordings from 530 
J20 mice, exhibited periods showing a peak in T-band power when animals were 531 
either awake (i.e. moving) or asleep, while periods of elevated G-band power 532 
were seen during sleep (Fig 4A). We evaluated the TGratio for each 8s interval 533 
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and related it to the number of IIS in the interval. Transient increases in TGwere 534 
observed during sleep and were associated with increased occurrences of IIS 535 
(Fig 4B).  536 
 537 
To quantify whether IIS were more likely in particular brain states, we next 538 
investigated the relationship between TGand IIS count/8s interval. As we were 539 
interested in discriminating between REM and NREM sleep, we limited the 540 
analysis to daylight hours when animals are more likely to be asleep. We used a 541 
value of TGand >2 to classify periods as NREM-like and REM-like respectively 542 
(Ewell et al., 2015). This revealed significantly higher spike counts during REM-543 
like vs NREM-like periods in all 5 animals (Fig 4B, p<0.0005 for all 5 animals,  544 
Markov Chain Monte Carlo generalised linear model)c. Interestingly, IIS were 545 
associated with increased TGin animals showing both weak and strong phase-546 
coupling (Fig 4C). Since sleep and wake are not predictive of IIS in animals with 547 
weak phase-coupling, this suggests that there is a mismatch between TGand 548 
behavioural state in animals with weak phase-coupling. Moreover, high 549 
TGstates are predictive of IIS, regardless of behavioural state.  550 
 551 
To examine the temporal dynamics of TGaround IIS, we evaluated the IIS-552 
triggered average of TG(Sedigh-Sarvestani et al., 2014) for 160s window around 553 
each interval in which at least one IIS was identified. In all animals, TGwas 554 
increased around the time of IIS relative to TG averaged around randomly 555 
sampled points (Fig 4D). In three strongly phase-coupled animals, TGreturned 556 
to baseline levels within the 160s window around the event. However, in the 557 
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weakly phase coupled animals, TGremained elevated above baseline levels in 558 
this window. The peak in the TGIIS-triggered average did not occur at t=0 in any 559 
of the animals. Since intervals neighbouring the IIS-containing interval show 560 
increased TG, this suggests that the IIS contribution to spectral power did not 561 
underlie the association between increases in TGand IIS probability. To further 562 
examine whether IIS could directly contribute to the increased TGwe compared 563 
TGin intervals with IIS to TG in the preceding intervals only in cases where the 564 
preceding interval contained no IIS. We found no significant difference in 565 
TGbetween intervals with IIS and the preceding interval (Linear mixed model, 566 
F2(1) = 0.35, p=0.56, data not shown)d. 567 
 568 
To determine whether the spectral ECoG patterns in J20 mice are a reflection of 569 
normal sleep or a result of pathology, we performed similar analysis of video-570 
scored ECoG data from 3 wild-type mice. As in the J20, intervals of strong 571 
Tpower were evident during wake and sleep, while periods of prominent 572 
Gband activity were seen in sleep. Transient increases in TGduring sleep akin 573 
to those seen in J20s were also observed in all WT animals, suggesting that such 574 
increases are a feature of normal sleep, and not pathological (Fig 5). To compare 575 
the distribution of TG during sleep between genotypes, we calculated the range 576 
and 90th percentile of TG while animals were asleep (using data for which we 577 
had video-scoring).  Group sizes were too small for statistical comparison but 578 
suggested that TG values spanned a narrower range in J20 mice than in WT mice 579 
(J20 mean range=(0.02, 10.0), 90th percentile=2.4, SD(1.1), n=4; WT mean 580 
range=(0.04, 19.3),  90th percentile =5.4, SD(1.4), n=3; data not shown). 581 
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 582 
No evidence of cholinergic changes in J20 mice 583 
Cholinergic levels exhibit a circadian modulation (Hut and Van der Zee, 2011), 584 
and high cholinergic tone is implicated in generating Toscillatory states (Buzsáki, 585 
2002). In addition, cholinergic dysfunction has been suggested to be a key 586 
feature of AD pathogenesis (Craig et al., 2011).  Recently, it has been suggested 587 
that cholinergic alterations may contribute to network excitability in the Tg2576 588 
model of AD (Kam et al., 2016). Hence, we hypothesized that cholinergic changes 589 
might underlie the brain-state dependent modulation of IIS in the J20 mice. We 590 
used immunohistochemistry to quantify the number of ChAT+ cells in the MS 591 
and DB, and asked whether the number of ChAT+ cells differs between J20 (n=7) 592 
and WT (n=5) mice. Fitting a linear mixed model to the data, we found no effect 593 
of genotype on the estimated number of ChAT+ cells in the MS or DB (Fig 6A; 594 
Linear mixed modelF p=0.99)e. 595 
 596 
AChE activity is reduced in AD (García-Ayllón et al., 2011). We assayed 597 
cholinergic function by measuring AChE activity. AChE activity was quantified by 598 
estimating the rate of thiocholine production in neocortical brain homogenates 599 
(see methods). There was no significant difference in the rate of thiocholine 600 
production in brain homogenates prepared from WT and J20 mice (V=15, p=0.06, 601 
n=5 WT/J20, Wilcoxon signed rank test, matched by day of assay, Fig 6B)f. We 602 
also wanted to directly test the effect of modulation of ACh levels on IIS. 603 
However, using oral administration of Donepezil at a dose previously suggested 604 
to achieve clinically relevant drug plasma levels (Dong et al., 2009) was 605 
ineffective at altering AChE activity in brain homogenates. In contrast, a positive 606 
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control treatment of direct application of neostigmine to brain homogenate led 607 
to a significant reduction in AChE activity (Fig 6B; Linear mixed model: 608 
F(4)=75.3, p<0.0001. Post-hoc using Tukey paired comparisons: p<0.0001 for 609 
neostigmine vs. each of the treatment and genotypes. p>0.05 for all other group 610 
comparisons)g. Two days of oral Donepezil administration at this dose did not 611 
affect the IIS rate in J20 mice (t(11)=0.8, p=0.43, paired t-test, data not shown)h. 612 
 613 
Sleep stage modulation of IIS in human AD 614 
The first intracranial recordings in humans with AD were recently reported and 615 
demonstrated marked activation of mesial temporal lobe (mTL) IIS during sleep 616 
compared to the awake state (Lam et al., 2017). We further analyzed the 617 
combined scalp EEG and intracranial electrode recordings from these two 618 
patients to better understand the relationship between sleep stage and mTL IIS 619 
rate in AD patients. One patient with advanced AD did not achieve REM sleep but 620 
showed mTL IIS preferentially during NREM sleep as opposed to waking states 621 
(Table 2, Patient 1). The second patient was a 67-year-old woman with amnestic 622 
mild cognitive impairment (aMCI), an early stage of AD that is thought to 623 
correspond to the early stage of AD modelled in our young J20 mice. The data 624 
from this patient was used to compare the frequency of IIS in wake, NREM and 625 
REM states. 626 
 627 
We analyzed 14.25 consecutive hours of combined scalp EEG and FO recordings 628 
from the aMCI patient, which spanned from ~ 7PM on the first day of FO 629 
recording (FOD1) to 9:15AM the following morning (FOD2). Further recordings 630 
were not analyzed, as the patient was initiated on treatment with the 631 
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anticonvulsant levetiracetam on the afternoon on FOD2.  Of note, the patient 632 
underwent implantation with FO electrodes on FOD1 from ~ 12:40PM – 1:50 PM 633 
and received sevoflurane, propofol and midazolam during the procedure.  She 634 
was awake and answering questions appropriately by 2:15PM on FOD1.    635 
 636 
We performed sleep staging of the recording using the full scalp EEG data, and 637 
measured mTL spike rates using the bilateral FO electrode data (Figure 7A,B).  638 
As described previously, we found that mTL spiking in the aMCI patient was 639 
largely activated during sleep.  In contrast to what we found in the young J20 640 
mice, mTL spiking in the aMCI patient occurred with highest frequency during 641 
NREM sleep stages, particularly during NREM3, and were lowest during REM 642 
sleep (Figure 7 and Table 2).   mTL IIS rates during REM sleep were also 643 
markedly lower than during wakefulness (Table 2).   We also calculated spectral 644 
power in the T and G bands, as well as the TG ratio, in the FO electrodes across 645 
sleep states (Figure 7C-E).  Increases in both T and Gpower were seen with 646 
deepening stages of NREM sleep, while a reduction was seen with REM sleep.  In 647 
contrast to what we observed in the J20 mice, the TG ratio was reduced during 648 




Network hyperexcitability is a feature of AD. Here we compared patterns of 653 
network hyperexcitability in two rodent models of AD, as well as in two AD 654 
patients, in order to reveal shared phenomenological features with the disease, 655 
We show that while J20, (hAPP overexpressing) mice exhibit frequent IIS as 656 
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previously reported, APPNL/F mice (that express APP at physiological levels) do 657 
not show evidence of network hyperexcitability. Moreover, IIS in J20s occur 658 
primarily during daylight hours, and this circadian fluctuation is accounted for 659 
by an increased probability of IIS during sleep. Interestingly, we found that IIS in 660 
J20 mice are modulated by brain state, with increased likelihood of IIS in brain 661 
states with high TG activity, a marker of REM sleep.  In contrast, patients with AD 662 
showed prevalent IIS during NREM sleep.  Moreover, in the one AD patient who 663 
exhibited REM sleep, IIS frequency was lowest in REM compared to other sleep 664 
states. 665 
 666 
Circadian dysfunction and network hyperexcitability in AD 667 
Brain network hyperexcitability in the form of IIS and seizures has now been 668 
reported in numerous models of AD pathology (reviewed in Scharfman, 2012; 669 
Born, 2015). Our data, along with those reported by others (Born et al., 2014; 670 
Kam et al., 2016) reveal that network hyperexcitability in animals models of AD 671 
can be modulated by the circadian cycle. Circadian disturbances in AD include 672 
sleep fragmentation, increased daytime somnolence, and sundowning, the 673 
phenomenon in which neuropsychiatric symptoms are heightened late in the day 674 
(Peter-Derex et al., 2015). Animal models of AD have also been reported to show 675 
disturbances in the circadian cycle, some of which overlap with patterns of 676 
circadian alterations seen in patients (Huitrón-Reséndiz et al., 2002; Vloeberghs 677 
et al., 2004; Wisor et al., 2005; Jyoti et al., 2010; Sterniczuk et al., 2010; Duncan et 678 
al., 2012; Roh et al., 2012). Our findings of circadian modulation of network 679 
hyperexcitability in AD raise the question of whether IIS might causally 680 
contribute to the alterations in circadian-coupled behaviour observed in AD. 681 
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Future work investigating the effects of anti-epileptic drugs on circadian 682 
alterations in AD would go towards answering this. 683 
 684 
Brain state modulation of network excitability 685 
Here we report that IIS in J20 animals are modulated by TGwith higher IIS rates 686 
seen in states of high TGduring sleep.  The spectral patterns of ECoG that we 687 
report here are in line with previous reports in WT mice, that have shown 688 
increases in cortical EEG T power in REM sleep relative to wake and NREM 689 
(Brankačk et al., 2010). We also report transient increases in TGin sleep in both 690 
WT and J20 mice.  Since these increases in TG occur in both WT and J20s, they 691 
are likely to be indicative of REM sleep periods (Ewell et al., 2015).  Given that 692 
J20 animals with strong circadian phase-coupling show highest IIS rates during 693 
sleep this suggests that IIS in these animals are associated with REM sleep.  694 
An alternative explanation for the association between IIS and high TG during 695 
sleep may be that IIS occur during ectopic T in sleep, in the absence of a 696 
concomitant drop in muscle tonus. A phenomenon of ictal activity during ectopic 697 
T has been reported in a mouse model of Huntington’s disease (Pignatelli et al., 698 
2012). Without simultaneous EMG recordings, the present data cannot 699 
conclusively distinguish between REM states and ectopic TIn the human data, 700 
analysis of TG ratios showed that these were lowest during periods of highest IIS 701 
frequency.  This argues against the idea of IIS coupled to ectopic T in humans, 702 
though a more definitive assessment will require data from more AD subjects as 703 
well as healthy elderly controls.   704 
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Our finding of an association between IIS and high TGis in line with recent 705 
reports that young Tg2576 model of AD as well as mice overexpressing WT-706 
hAPP also demonstrate IIS predominantly during states of high T which the 707 
authors suggest is indicative of REM sleep (Kam et al., 2016).  708 
The findings that IIS in multiple mouse models of AD are most likely to occur in 709 
REM-like states begs the question of what makes REM a pro-ictal state in these 710 
models. Both REM sleep and the awake state share common features of high 711 
TGactivity and high cholinergic tone (Vazquez and Baghdoyan, 2001; Lee et al., 712 
2005), yet IIS occur much less frequently in the awake state in these models.  713 
There are several potential explanations for this.  Firing rates of hippocampal 714 
neurons increase during REM (Grosmark et al., 2012), which might contribute to 715 
the propensity to seize. In addition, systems that normally show distinct activity 716 
in REM sleep vs. waking and NREM sleep might contribute to the pro-ictal REM 717 
state in these models (Sedigh-Sarvestani et al., 2014; Ewell et al., 2015; Kam et al., 718 
2016). Unlike cholinergic neurons, which increase their activity in both REM and 719 
waking, monoaminergic neurons in brainstem nuclei (including the locus 720 
coeruleus and the tuberomammillary nucleus) as well as the dorsal raphe 721 
nucleus of the hypothalamus, show differential activity between these brain 722 
states.  These neurons are highly active in waking, exhibit low firing rates in 723 
NREM sleep, and are quiescent during REM sleep (Lee and Dan, 2012).  It may be 724 
that brain state modulation of one or more of these systems is disrupted in these 725 
mouse AD models, and other forms of epilepsy which show REM-coupling 726 
(Sedigh-Sarvestani et al., 2014; Ewell et al., 2015). 727 
The present study quantified cholinergic neurons in MS and DB. Cholinergic 728 
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neurons in laterodorsal tegmental and pedunculopontine tegmental nuclei of the 729 
pontomesencephalic tegmentum have been suggested to control REM onset (Van 730 
Dort et al., 2015). In the rat, these neurons have been shown to be active during 731 
both wake and REM, however, firing rates are higher in REM, and correlate with 732 
TG(Boucetta et al., 2014) Thus, changes to these neurons are also potential 733 
candidates for mediating the pro-ictal nature of REM sleep in J20 mice. 734 
Kam et al.,(2016) reported that MS-DB cholinergic neuron number was 735 
unchanged in young Tg2576 mice. However, they found evidence to support the 736 
notion that overactivity of cholinergic neurons might contribute to IIS by 737 
showing that antagonism of muscarinic receptors reduced IIS in these animals.  738 
Hence they concluded that IIS during REM might be the result of cholinergic 739 
hyperfunction. We did not find evidence for cholinergic changes in J20 mice as 740 
quantified by the number of cholinergic neurons in MS-DB, or AChE activity. If 741 
cholinergic activity is indeed unaltered in J20 mice, future experiments using 742 
muscarinic antagonism in J20 mice could be used to investigate whether 743 
atropine can act to reduce IIS by reducing overall neuronal excitability, rather 744 
than by reversing cholinergic hyperfunction. 745 
Our assay of cholinergic function was based on measurements of AChE enzymic 746 
activity in brain homogenate. There was no significant difference between AChE 747 
levels in WT and J20, or with donepezil treatment. While it is possible that post-748 
mortem degradation of AChE could have masked differences in AChE levels, the 749 
robust effect of neostigmine supports the conclusion that the tissue contained 750 
functional AChEs. 751 
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In a subset of our animals, IIS were weakly-coupled to the circadian cycle and the 752 
sleep-wake pattern, but were still modulated by TG.  This suggests that the 753 
relationship between TGand behavioural state might be disturbed in these 754 
animals. It is possible that these animals also exhibited greater disturbances in 755 
other elements of the circadian-cycle, such as a circadian decoupling of sleep 756 
quantity/quality.  757 
During both REM and NREM, hippocampal neurons have been shown to replay 758 
firing patterns that were experienced prior to sleep (Skaggs and McNaughton, 759 
1996; Louie and Wilson, 2001), and such precisely timed sequences are likely to 760 
be involved in the memory facilitation role of sleep. IIS are thought to arise from 761 
depolarization and synchronous firing of neurons. This firing is followed by an 762 
inhibition and reduction of firing (Holmes and Lenck-Santini, 2006).  Thus, IIS 763 
during sleep are likely to interfere with the coordinated replay of firing 764 
sequences, and consequently, would be expected to contribute to memory 765 
impairments. In support of this, it has recently been shown that reducing IIS by 766 
treatment with anti-epileptic drugs, rescues memory deficits in J20s (Sanchez et 767 
al., 2012).   768 
Relationship between IIS and AD pathology in mouse models 769 
Here we report that while IIS are prevalent in hAPP overexpressing mice, 770 
APPNL/F mice that exhibit AE pathology without APP overexpression, do not 771 
exhibit IIS at two ages preceding widespread plaque deposition (8 and 12 772 
months). This finding is in line with other reports that it is overexpression of 773 
hAPP that is causal in generating network hyperexcitability in these animal 774 
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models (Born et al., 2014; Xu et al., 2015; Kam et al., 2016).  An alternative 775 
explanation of the presence of IIS in J20 but not APPNL/F mice may be differences 776 
in the levels of AE between the two models. However, levels of soluble AE in 6 777 
month old J20 and 12 month old APPNL/F are comparable, and levels of total $E 778 
are higher in APPNL/F (Shankar et al., 2009; Saito et al., 2014). Thus it is unlikely 779 
that higher levels of AE in the J20s are a cause of IIS in this model.   780 
Interestingly, APPNL/F mice begin to exhibit cognitive deficits at 8 months of age 781 
(Masuda et al., 2016), which suggests that cognitive deficits at these ages are not 782 
the result of IIS, as has been suggested for J20s (Sanchez et al., 2012).  Moreover, 783 
differences in the types of memory affected in J20 and APPNL/F at ages preceding 784 
overt plaque deposition have been reported. Specifically, 4 – 6 month old J20s 785 
show impairments in hippocampal dependent spatial memory (Sanchez et al., 786 
2012). In contrast, in 8-month old APPNL/F mice, spatial memory as assayed by a 787 
place preference task is intact. However, place-avoidance memory, which is also 788 
dependent on amygdala-circuits (Wilensky et al., 2000), is impaired (Masuda et 789 
al., 2016). It may be that hippocampus dependent processes are susceptible to 790 
interference by IIS while the disturbances in the non-hippocampal circuits result 791 
from processes independent of IIS. 792 
Differential sleep-stage coupling between mouse models of AD and human AD 793 
Lam et al., (2017) recently used intracranial electrode recordings to detect mTL 794 
IIS in two AD patients without a history of epilepsy. Here, we report that in these 795 
patients, IIS were predominantly associated with NREM sleep (ie. low TG. In the 796 
patient with aMCI, IIS occurred most frequently in N3 sleep and were least 797 
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frequent in REM, with a greater than 4.5-fold difference in spike rates between 798 
N3 and REM.  In the AD patient, frequent IIS were seen during NREM sleep, 799 
though REM sleep was absent from this patient’s brief recording, in line with 800 
previous reports of REM deficits in AD (Vitiello et al., 1984).  Our findings from 801 
intracranial electrodes in AD patients are consistent with prior scalp EEG studies 802 
by Vossel et al., (2016), who reported that epileptiform discharges are highly 803 
prevalent in  sleep stages >2 (although the authors did not differentiate between 804 
REM and NREM sleep).  Although the means of characterising sleep differed 805 
between rodents and patients, combined, these results point to important 806 
differences in sleep stage coupling of epileptiform activity between rodent AD 807 
models and humans with AD and suggest that the specific mechanisms that 808 
underlie hyperexcitability in AD may differ between certain mouse models and 809 
humans.  810 
Analysis of ictal and inter-ictal activity in epilepsy patients has led the view that 811 
NREM sleep is a generally pro-ictal state, whereas REM sleep is an anti-ictal state 812 
(Sammaritano et al., 1991; Herman et al., 2001; Minecan et al., 2002; Ng and 813 
Pavlova, 2013).  Many animal models of epilepsy have also shown that seizures 814 
are more frequent in NREM and rarely occur in REM (Shouse et al., 2000) .  815 
Interestingly, rodent models of the same type of epilepsy can still exhibit 816 
differences in the sleep-stage coupling of epileptiform activity.  For example, in 817 
both the kindling as well as the pilocarpine models of temporal lobe epilepsy in 818 
rats, IIS are most common during NREM sleep (Colom et al., 2006; Gelinas et al., 819 
2016).  In contrast, rats with either the tetanus toxin or the low-dose kainate 820 
models of temporal lobe epilepsy have seizures that occur most commonly 821 
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during REM sleep (Sedigh-Sarvestani et al., 2014; Ewell et al., 2015).  Based on 822 
this, we hypothesize that different mouse models of AD may have specific 823 
mechanisms underlying their network hyperexcitability, which could be 824 
differentially expressed through sleep-stage coupling of IIS.  We propose that 825 
sleep-stage coupling of IIS should be an important factor for identifying mouse 826 
AD models that more closely resemble the EEG signature of network 827 
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Figures 838 
Figure 1: Inter-ictal spikes (IIS) are prevalent in J20 mice, but not in APP knock-839 
in mice. (A) ECoG trace recorded from a J20 mouse showing IIS. Inset is 250ms 840 
expansion around IIS event marked by *. (B) Empirical cumulative distribution 841 
frequency plots for individual animals quantifying the number of detected IIS in 842 
8s intervals across 3 days of recording in WT and J20s. Colours represent 843 
distributions for individual animals. (C) Plot showing the proportion of intervals 844 
with one or more detected IIS in WT and J20.  (D) Plot showing the proportion of 845 
intervals with one or more detected IIS in WT and APPNL/F at 8 months and 12 846 
months. Bars represent medians. Whiskers extend to 1.5 IQR. *** p<0.001. 847 
 848 
Figure 2: Circadian modulation of IIS. (A) Circular histogram of IIS counts over 849 
three days of recording in an individual J20 mouse plotted on 24hr cycle. Light 850 
condition indicated by shading. For the animal shown, ߮ூூௌ= 14h38 and U=0.43. 851 
(B) Summary data for ߮ூூௌ vs U for all animals, shown on circular plot. Solid 852 
symbols are strongly-coupled animals. Weakly coupled animals are shown with 853 
orange fill.  854 
 855 
Figure 3: The probability of IIS is modulated by behavioural state in strongly 856 
phase-coupled animals. (A) IIS count/8s interval versus time over 2 hours of 857 
ECoG recording in a J20 mouse, with sleep and wake indicated by shading. (Bi) 858 
Mean spike rate in sleep and wake condition for strongly and weakly phase 859 
coupled animals. Error bars: 95% CI. (ii) Circular histograms for a strongly (left) 860 
and weakly (right) phase coupled animals using conventions as in Fig 2A. 861 
 862 
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Figure 4: IIS occur during high TG states. (A) 8s ECoG signals (left) and 863 
corresponding power spectra (right) during different behavioural states 864 
recorded from a J20 mouse. A single IIS is seen in the sleep high T state (ii). (B) 865 
Time series of Gpower, T power, TG and spike count per 8s intervals across 2 866 
hours of ECoG recorded from the same J20 mouse as shown in A. Black/grey 867 
symbols indicate sleep/wake as classified by simultaneous video data.  Red 868 
symbols and vertical dotted lines indicate the 8s intervals for which the ECoG 869 
signal is shown in panel A (C) Spike number per 8s interval as a function of TGin 870 
5 animals (represented by different colours and connected by lines). The 871 
increase spike count in intervals with high TG was seen in animals with both 872 
strong (filled symbols) and weak (open symbols) circadian phase-coupling. *** 873 
p<0.001 (D) IIS-triggered averages of TG for 5 individual animals (black) and 874 
windowed averages triggered around 2000 randomly sampled points (grey) 875 
show an increased TG around IIS. Strong/weak coupling shown in filled/open 876 
symbols. Error bars in B and C represent 95% CI.  877 
 878 
Figure 5. Transient increases in TG are non-pathological features of sleep. (A) 8s 879 
ECoG signals (left) and corresponding power spectra (right) during different 880 
behavioural states recorded from a WT mouse. (B) Time series of Gpower, T 881 
power and TG per 8s interval across 2 hours of ECoG recorded from same WT 882 
mouse as shown in A. Black/grey symbols indicate sleep/wake as classified by 883 
simultaneous video data.  Red symbols and vertical dotted lines indicate the 8s 884 
intervals for which the ECoG signal is shown in panel A. 885 
 886 
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Figure 6: No evidence of cholinergic alterations in J20s. (A) Immunostained 887 
brain section showing ChAT+ cells in medial septum (MS) and diagonal band of 888 
Broca (DB). Lower panel shows zoomed in region of upper panel (left) and 889 
corresponding regions of a negative control stained section (right). Upper right: 890 
quantification of stereological estimates of ChAT+ cell count in MS and DB in WT 891 
and J20. (B) AChE activity was assayed by the rate of thiocholine production in 892 
brain homogenate from WT and J20 in control conditions and following oral 893 
administration of donepezil (DPZ). The AChE activity was compared to a positive 894 
control of direct application of neostigmine (10PM) to the brain homogenate. 895 
Experimental repeat groups are indicated by different colours and connected 896 
lines. *** p<0.001. 897 
 898 
Figure 7: Sleep stage coupling of mesial temporal lobe (mTL) spiking in a human 899 
with aMCI, a suspected early stage of AD.  (A) Hypnogram showing the patient’s 900 
sleep architecture, spanning from ~ 7PM on FOD1 to 9:15AM on FOD2.  (B) Bar 901 
plot showing instantaneous mTL lobe spike rates over the course of the 902 
recording.  Bars are colored by sleep stage, with light green for Wake, light blue 903 
for NREM (includes NREM1, NREM2, and NREM3), and dark blue for REM.  The 904 
patient had three brief subclinical seizures (SZ) from the left FO electrodes 905 
during this recording, the timing of which is depicted by red vertical bars.  (C-E): 906 
Plots showing (C) G power (0-4Hz), (D) T power (4-12Hz), and (E) TG ratio of 907 
bilateral mTL activity, based on FO electrodes recordings.  Dots represent the 908 
spectral power for each non-overlapping 30 second window of the recording.  909 
Power is measured in arbitrary units. 910 
 911 
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Table 1: Statistical table 912 
 913 
Table 2: Average mTL spike rates were evaluated from foramen ovale electrodes 914 
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  1 
 Patient #1 (AD dementia) Patient #2 (aMCI) 
Sleep Stage Total Hours in Record 




Average spike rate 
(spikes/hour) 
Wake 4.7 11 5.2 329 
NREM1 0.7 31 1.5 670 
NREM2 2.1 80 3.8 739 
NREM3 1.4 62 3.1 903 
REM 0 n/a 0.7 159 
 
